[The effect of antileukemic drugs on superoxide (O2-) production by human neutrophils].
Katoh
M
M
Shirai
T
T
Umeda
M
M
Yamaguchi
R
R
Kaneko
H
H
Ishikawa
I
I
Yamauchi
M
M
Kojima
N
N
D015250:Aclarubicin / Q000031:analogs & derivatives*; D000970:Antineoplastic Agents / Q000494:pharmacology*; D003561:Cytarabine / Q000031:analogs & derivatives / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007938:Leukemia / Q000188:drug therapy / Q000378:metabolism; D009279:Naphthacenes / Q000494:pharmacology; D009504:Neutrophils / Q000187:drug effects / Q000378:metabolism*; D013481:Superoxides / Q000378:metabolism*
D000970:Antineoplastic Agents; D009279:Naphthacenes; C011157:aclacinomycins; D003561:Cytarabine; D013481:Superoxides; D015250:Aclarubicin; C015019:enocitabine